Misfeldt Dayton

Director at VIRX

Sold, on record
$9.5M
Dollars the filings state
Form 4 sales
3
Latest Jul 24, 2015
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • VIRXViracta Therapeutics, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale VIRXUnusual
    Aug 12, 2014 2014

    Sold 743,700 shares at $6.64 ($4.9M)

    Misfeldt Dayton, Director, 10% owner

    Sold 89% of holdings ($5.5M position)91,495 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale VIRXUnusual
    Aug 28, 2014 +16 days

    Sold 300,700 shares at $7.98 ($2.4M)

    Misfeldt Dayton, Director, 10% owner

    Sold 77.8% of holdings ($3.1M position)85,872 shares leftFiling

  3. 3 Form 4 sale VIRXUnusual
    Jul 24, 2015 +330 days

    Sold 635,702 shares at $3.46 ($2.2M)

    Misfeldt Dayton, Director

    Sold 85.8% of holdings ($2.6M position)105,134 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Misfeldt Dayton
Source
Jul 24, 2015Dec 21, 2015VIRXDirectorForm 4 sale635,702$2.2M85.8%UnusualSEC
Aug 28, 2014Aug 29, 2014VIRXDirector, 10% ownerForm 4 sale300,700$2.4M77.8%UnusualSEC
Aug 12, 2014Aug 12, 2014VIRXDirector, 10% ownerForm 4 sale743,700$4.9M89.0%UnusualSEC